The molecular phenotypes of injury, steatohepatitis, and fibrosis in liver transplant biopsies in the INTERLIVER study. Issue 3 (3rd December 2021)
- Record Type:
- Journal Article
- Title:
- The molecular phenotypes of injury, steatohepatitis, and fibrosis in liver transplant biopsies in the INTERLIVER study. Issue 3 (3rd December 2021)
- Main Title:
- The molecular phenotypes of injury, steatohepatitis, and fibrosis in liver transplant biopsies in the INTERLIVER study
- Authors:
- Madill‐Thomsen, Katelynn S.
Abouljoud, Marwan
Bhati, Chandra
Ciszek, Michał
Durlik, Magdalena
Feng, Sandy
Foroncewicz, Bartosz
Francis, Iman
Grąt, Michał
Jurczyk, Krzysztof
Klintmalm, Goran
Krasnodębski, Maciej
McCaughan, Geoff
Miquel, Rosa
Montano‐Loza, Aldo
Moonka, Dilip
Mucha, Krzysztof
Myślak, Marek
Pączek, Leszek
Perkowska‐Ptasińska, Agnieszka
Piecha, Grzegorz
Reichman, Trevor
Sanchez‐Fueyo, Alberto
Tronina, Olga
Wawrzynowicz‐Syczewska, Marta
Więcek, Andrzej
Zieniewicz, Krzysztof
Halloran, Philip F. - Abstract:
- Abstract : To extend previous molecular analyses of rejection in liver transplant biopsies in the INTERLIVER study (ClinicalTrials.gov #NCT03193151), the present study aimed to define the gene expression selective for parenchymal injury, fibrosis, and steatohepatitis. We analyzed genome‐wide microarray measurements from 337 liver transplant biopsies from 13 centers. We examined expression of genes previously annotated as increased in injury and fibrosis using principal component analysis (PCA). PC1 reflected parenchymal injury and related inflammation in the early posttransplant period, slowly regressing over many months. PC2 separated early injury from late fibrosis. Positive PC3 identified a distinct mildly inflamed state correlating with histologic steatohepatitis. Injury PCs correlated with liver function and histologic abnormalities. A classifier trained on histologic steatohepatitis predicted histologic steatohepatitis with cross‐validated AUC = 0.83, and was associated with pathways reflecting metabolic abnormalities distinct from fibrosis. PC2 predicted histologic fibrosis (AUC = 0.80), as did a molecular fibrosis classifier (AUC = 0.74). The fibrosis classifier correlated with matrix remodeling pathways with minimal overlap with those selective for steatohepatitis, although some biopsies had both. Genome‐wide assessment of liver transplant biopsies can not only detect molecular changes induced by rejection but also those correlating with parenchymal injury,Abstract : To extend previous molecular analyses of rejection in liver transplant biopsies in the INTERLIVER study (ClinicalTrials.gov #NCT03193151), the present study aimed to define the gene expression selective for parenchymal injury, fibrosis, and steatohepatitis. We analyzed genome‐wide microarray measurements from 337 liver transplant biopsies from 13 centers. We examined expression of genes previously annotated as increased in injury and fibrosis using principal component analysis (PCA). PC1 reflected parenchymal injury and related inflammation in the early posttransplant period, slowly regressing over many months. PC2 separated early injury from late fibrosis. Positive PC3 identified a distinct mildly inflamed state correlating with histologic steatohepatitis. Injury PCs correlated with liver function and histologic abnormalities. A classifier trained on histologic steatohepatitis predicted histologic steatohepatitis with cross‐validated AUC = 0.83, and was associated with pathways reflecting metabolic abnormalities distinct from fibrosis. PC2 predicted histologic fibrosis (AUC = 0.80), as did a molecular fibrosis classifier (AUC = 0.74). The fibrosis classifier correlated with matrix remodeling pathways with minimal overlap with those selective for steatohepatitis, although some biopsies had both. Genome‐wide assessment of liver transplant biopsies can not only detect molecular changes induced by rejection but also those correlating with parenchymal injury, steatohepatitis, and fibrosis, offering potential insights into disease mechanisms for primary diseases. Abstract : Genome‐wide microarray assessment of 337 liver transplant biopsies by the Molecular Microscope Diagnostic System (MMDx) can not only detect molecular rejection but also molecular changes in gene expression induced by parenchymal injury, steatohepatitis, and fibrosis, which may offer mechanistic insights and additional diagnostic precision into primary liver diseases. … (more)
- Is Part Of:
- American journal of transplantation. Volume 22:Issue 3(2022)
- Journal:
- American journal of transplantation
- Issue:
- Volume 22:Issue 3(2022)
- Issue Display:
- Volume 22, Issue 3 (2022)
- Year:
- 2022
- Volume:
- 22
- Issue:
- 3
- Issue Sort Value:
- 2022-0022-0003-0000
- Page Start:
- 909
- Page End:
- 926
- Publication Date:
- 2021-12-03
- Subjects:
- basic (laboratory) research/science -- biopsy -- liver transplantation/hepatology -- microarray/gene array -- rejection
Transplantation of organs, tissues, etc -- Periodicals
617.95 - Journal URLs:
- https://www.sciencedirect.com/journal/american-journal-of-transplantation ↗
http://www.blackwellpublishing.com/journal.asp?ref=1600-6135&site=1 ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1600-6143 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/ajt.16890 ↗
- Languages:
- English
- ISSNs:
- 1600-6135
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 0838.850000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 25898.xml